Efficacy of anidulafungin in 539 patients with invasive candidiasis: a patient-level pooled analysis of six clinical trials.
Fiche publication
Date publication
avril 2017
Journal
The Journal of antimicrobial chemotherapy
Auteurs
Membres identifiés du Cancéropôle Est :
Pr HERBRECHT Raoul
Tous les auteurs :
Kullberg BJ, Vasquez J, Mootsikapun P, Nucci M, Paiva JA, Garbino J, Yan JL, Aram J, Capparella MR, Conte U, Schlamm H, Swanson R, Herbrecht R
Lien Pubmed
Résumé
To evaluate the efficacy of anidulafungin for the treatment of candidaemia and invasive candidiasis in a large dataset, including patients with deep-seated tissue candidiasis, neutropenia and infection due to non- albicans Candida species.
Mots clés
Administration, Intravenous, Adolescent, Adult, Aged, Aged, 80 and over, Anidulafungin, Antifungal Agents, administration & dosage, Candidiasis, Invasive, drug therapy, Clinical Trials as Topic, Echinocandins, administration & dosage, Female, Humans, Male, Middle Aged, Treatment Outcome, Young Adult
Référence
J. Antimicrob. Chemother.. 2017 Apr;: